<DOC>
	<DOCNO>NCT02325245</DOCNO>
	<brief_summary>The purpose study investigate effect metformin prevent frailty pre-frail non-diabetic elderly . Several outcome measure study frailty status , quality life , handgrip strength , gait speed , serum myostatin level . We hypothesize metformin 16 week could prevent frailty pre-frail elderly .</brief_summary>
	<brief_title>Effects Metformin Pre-frail Elderly</brief_title>
	<detailed_description />
	<mesh_term>Metformin</mesh_term>
	<criteria>1 . Prefrail elderly ; 2 . Capable understand carryout instruction . 1 . Unwilling join study ; 2 . Diabetes mellitus ( oral glucose tolerance test ) ; 3 . Abbreviated Mental Test ( AMT ) score &lt; 8 ; 4 . Geriatric Depression Scale ( GDS ) score &gt; = 10 ; 5 . Body mass index ( BMI ) &lt; 18,5 Kg/m2 ; 6 . Malnutrition ( accord Mini Nutritional Assessment/MNA ) ; 7 . Liver cirrhosis , severe liver dysfunction , serum ALT level &gt; 3 time upper normal limit ; 8 . Acute illness inclusion period , eg . pneumonia , pain due acute arthritis ( visual analog scale &gt; 6/10 ) , stroke attack , crisis hypertension ; 9 . Severe cardiac dysfunction : acute decompensated heart failure and/or chronic heart failure functional class III IV ( New York Heart Association classification ) ; 10 . Severe pulmonary dysfunction : acute exacerbation chronic obstructive lung disease stage III IV ( GOLD classification ) , and/or PaO2 level &lt; 60 mmHg ; 11 . Allergy metformin .</criteria>
	<gender>All</gender>
	<minimum_age>60 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>Frailty</keyword>
	<keyword>Pre-frailty</keyword>
	<keyword>Metformin</keyword>
	<keyword>Elderly</keyword>
	<keyword>Quality life</keyword>
	<keyword>Handgrip</keyword>
	<keyword>Gait speed</keyword>
	<keyword>Myostatin</keyword>
</DOC>